期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
SYNTHESIS AND CHARACTERISTICS OF A CHELATING RESIN AS AN EXTRACTANT AND CHROMOGENIC REAGENT OF HEAVY METAL IONS IN SOLID PHASE EXTRACTION 被引量:4
1
作者 张田林 Hui-min Ma +2 位作者 Jia-jia Wang cai-yan zhu Bing-bing Wang 《Chinese Journal of Polymer Science》 SCIE CAS CSCD 2013年第8期1108-1116,共9页
A new chelating resin (CPS-DMA-SABA) was synthesized with the chloromethylated crossqinked polystyrene porous beads (CPS) as raw materials, which were bonded with salicylidene-o-aminobenzoic acid (SABA) on the s... A new chelating resin (CPS-DMA-SABA) was synthesized with the chloromethylated crossqinked polystyrene porous beads (CPS) as raw materials, which were bonded with salicylidene-o-aminobenzoic acid (SABA) on the surface via a quaternary ammonium unit as a linker. The results showed that CPS-DMA-SABA would easily change into a zwitterionic chelating resin (CPS-DMA-SABZ) when washed with distilled water. CPS-DMA-SABA was characterized by elemental analysis, infrared spectra and thermo-gravimetric analysis. The ion sorption capacities of CPS-DMA-SABA were found to be 1916 μg/g for Zn2+ withpH at 4.5, 1620μg/g for Cu2+ with pH at 6.2, 1291 μg/g for Ni2+ withpH at 6.6 and 780 μg/g for Cr3+ withpH at 5.5, respectively. The experiments showed CPS-DMA-SABA also changed its color when meeting with the metal ion in the aqueous solution. As a consequence, CPS-DMA-SABA can not only be used as a solid phase extractant but also an indicator for confirming the heavy metal ion in solutions. 展开更多
关键词 Solid phase extractant Zwitterionic chelating resin Heavy metal ion o-Aminobenzoic acid Synthesis.
原文传递
Antitumor immunity of low-dose cyclophosphamide:changes in T cells and cytokines TGF-beta and IL-10 in mice with colon-cancer liver metastasis 被引量:1
2
作者 Xiao-Ming Huang Nan-Rong Zhang +7 位作者 Xu-Tao Lin cai-yan zhu Yi-Feng Zou Xiao-Jian Wu Xiao-Sheng He Xiao-Wen He Yun-Le Wan Ping Lan 《Gastroenterology Report》 SCIE EI 2020年第1期56-65,I0002,共11页
Background:The tumor immune microenvironment is one of the most important prognostic factors in liver metastasis from colorectal cancer.Low-dose cyclophosphamide(CTX)is widely believed to be involved in the modulation... Background:The tumor immune microenvironment is one of the most important prognostic factors in liver metastasis from colorectal cancer.Low-dose cyclophosphamide(CTX)is widely believed to be involved in the modulation of the immune system.However,the underlying mechanism of low-dose CTX remains unknown.This study aimed to investigate the antitumor immunity of low-dose CTX in the treatment of colon-cancer liver metastasis.Methods:Thirty mice were randomly divided into five groups.After liver metastasis was established in colon-cancer models,mice in the treatment groups were injected with low-dose CTX(20 mg/kg)at different time points.Liver and spleen tissues were examined for T-cell markers via flow cytometry.Interleukin(IL)-10 and transforming growth factor(TGF)-b1 expression levels in liver tissues were analysed by immunohistochemistry.Serum interferon(IFN)-c and IL-10 levels were detected by enzyme-linked immunosorbent assay.An additional 20 mice were randomly allocated into two groups and the survival times were recorded.Results:The expression levels of CD4^(+)T cells,CD8^(+)T cells,and IFN-c were down-regulated,whereas those of IL-10 and TGF-b1 were up-regulated in liver metastasis from colon cancer in mice.Furthermore,the local and systemic microenvironments of the liver were altered,which led to reduced antitumor immune responses and subsequently liver metastasis.However,treatment with low-dose CTX reversed these effects.The survival times of mice treated with low-dose CTX were significantly longer than those of the other groups.Conclusions:Low-dose CTX exerts its antitumor activity by changing the systemic and local immune microenvironments and enhancing immune regulation inmice.CTX could be used as a drug to prevent and treat livermetastasis from colon cancer. 展开更多
关键词 colon cancer liver metastasis CYCLOPHOSPHAMIDE immune microenvironment
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部